SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026313
Filing Date
2021-11-12
Accepted
2021-11-12 08:34:48
Documents
89
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20210930_10q.htm   iXBRL 10-Q 1404967
2 EXHIBIT 31.1 ex_303906.htm EX-31.1 8580
3 EXHIBIT 31.2 ex_303907.htm EX-31.2 8604
4 EXHIBIT 32.1 ex_303908.htm EX-32.1 4409
5 EXHIBIT 32.2 ex_303909.htm EX-32.2 4450
  Complete submission text file 0001437749-21-026313.txt   7849958

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nby-20210930.xsd EX-101.SCH 91850
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20210930_cal.xml EX-101.CAL 49971
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20210930_def.xml EX-101.DEF 564157
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20210930_lab.xml EX-101.LAB 458239
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20210930_pre.xml EX-101.PRE 596906
11 EXTRACTED XBRL INSTANCE DOCUMENT nby20210930_10q_htm.xml XML 1255300
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 211399966
SIC: 2834 Pharmaceutical Preparations